Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 1

Therapy of autoimmune bullous diseases

Authors Diya F Mutasim

Published 15 March 2007 Volume 2007:3(1) Pages 29—40



Diya F Mutasim

Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, OH, USA

Abstract: Autoimmune bullous diseases result from an immune response to molecular components of the desmosome or basement membrane. Bullous diseases are associated with a high degree of morbidity and occasional mortality. Therapy of bullous diseases consists of suppressing the immune system, controlling inflammation and improving healing of erosions. The therapeutic agents used in the treatment of bullous diseases may be associated with high morbidity and occasional mortality. Successful treatment requires understanding of the pathophysiology of the disease process and the pharmacology of the drugs being used.  

Keywords: autoimmune, bullous, therapy